Biotech companies are exploring multiple targets in the fight against neuroinflammation. Experts say these projects could yield the next breakthrough in treating Alzheimer’s disease.
Neuroinflammation: The Natural Next Alzheimer’s Target? Read More »
With one disease-modifying therapy already reaching patients and another expected to soon, several biopharma companies anticipate key data for novel assets in the coming 12 months.
Una selección de artículos que abordan aspectos muy diversos de los beneficios del ejercicio para la salud
The drugstore retailer said it still has “significant cost savings and growth goals to deliver” as it confirmed further downsizing of its workforce.
The Renton, Washington-based nonprofit health system plans to spend millions to settle allegations it skirted charity care obligations between 2018 and 2023.
Providence erases or refunds $158M in medical bills Read More »
The rule marks the first substantial changes to treatment and delivery standards at opioid treatment programs in more than 20 years.
HHS finalizes rule on telehealth at opioid treatment programs Read More »
The Evoque valve will serve patients with few treatment options, wrote RBC analyst Shagun Singh.
The health insurer sees Medicare Advantage as an area for future growth, despite selling the division for $3.7 billion earlier this week. Cigna’s CEO called the sale a “win-win” on a call with investors Friday.
Kevin Hykes joins the company as it looks to grow the market for its device to improve heart failure symptoms.
The U.S. Department of Health and Human Services on Thursday released new data showing that Americans pay three times more for prescription drugs than other developed countries and nearly 10 times more for insulin.
Drug Pricing Reforms Front and Center as 2024 Election Ramps Up Read More »
